Kiran Mazumdar Shaw

Engineering the future: India's opportunity in synthetic biology

The Union Cabinet's approval of the BioE3 policy is a landmark step in the right direction. But the window of opportunity is narrow

Kiran Mazumdar-Shaw: e-health push can build 'Swastha Bharat'

In 2017 govt should push for increased adoption of technology to transform public health care system

Kiran Mazumdar Shaw: Life science developments to look out for in 2016

The year ahead promises a new paradigm in health care worldwide

A 'play safe' budget: Kiran Mazumdar-Shaw

FM merely voiced his worries for the Indian economy but was not able to articulate path-breaking solutions

Ranbaxy a wake-up call for Indian pharma

The industry must take strong collective action to protect the reputation it enjoys in global markets